Penn Engineering secured a multi-million-dollar contract with Wellcome Leap under the organization’s $60 million RNA Readiness + Response (R3) program, which is jointly funded with … Read More ›
Author: Melissa Pappas
The rise of drug-resistant bacteria infections is one of the world’s most severe global health issues, estimated to cause 10 million deaths annually by the … Read More ›
Our bodies are equipped with specialized white blood cells that protect us from foreign invaders, such as viruses and bacteria. These T cells identify threats … Read More ›
From COVID vaccines to cancer immunotherapies to the potential for correcting developmental disorders in utero, mRNA-based approaches are a promising tool in the fight against … Read More ›
Most organisms have proteins that react to light. Even creatures that don’t have eyes or other visual organs use these proteins to regulate many cellular … Read More ›
Our body’s natural line of defense against infection and disease, as well as cancer, is our immune system equipped with T cells, a type of … Read More ›
Solar panels, cameras, biosensors and fiber optics are technologies that rely on photodetectors, or sensors that convert light into electricity. Photodetectors are becoming more efficient … Read More ›
Penn Health-Tech’s Nemirovsky Engineering and Medicine Opportunity (NEMO) Prize awards $80,000 to support early-stage ideas joining engineering and medicine. The goal of the prize is … Read More ›
While biologists and chemists race to develop new antibiotics to combat constantly mutating bacteria, predicted to lead to 10 million deaths by 2050, engineers are … Read More ›
Founded in 2009 in commemoration of the 20th anniversary of the peaceful fall of the Berlin Wall, the Falling Walls Science Summit gathers innovative researchers … Read More ›